HIV Pre-exposure Prophylaxis (PrEP) in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes, and Cost-effectiveness

BACKGROUND: The combination of tenofovir and emtricitabine (TDF/FTC) shows promise as HIV pre-exposure prophylaxis (PrEP). We sought to forecast clinical, epidemiologic, and economic outcomes of PrEP, taking into account uncertainties regarding efficacy, risk of resistance and toxicity, behavioral d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Paltiel, A. David, Freedberg, Kenneth A., Scott, Callie A., Schackman, Bruce R., Losina, Elena, Wang, Bingxia, Seage, George R., Sloan, Caroline E., Sax, Paul E., Walensky, Rochelle P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2876329/
https://ncbi.nlm.nih.gov/pubmed/19193111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/597095
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados